# LIRAGLUTIDE
> **ANDA213155** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN INSTITUTIONAL · Approved 2026-06-15
## Drug
- **FDA Application Number:** ANDA213155
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LIRAGLUTIDE
- **Generic name:** Liraglutide
- **Active ingredients:** LIRAGLUTIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** MYLAN INSTITUTIONAL
- **First approval:** 2026-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213155)
---
*MORVS · CC0 1.0*